Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

I U Haq

Showing results (11-20 of 33) with videos related to

Pageof 4
Sort By:
QJM : Monthly Journal of the Association of Physicians|January 11, 2000
Prediction of coronary risk for primary prevention of coronary heart disease: a comparison of methodsI U Haq, L E Ramsay, P R Jackson, et al.
BMJ (Clinical Research Ed.)|July 22, 1995
Interventions in OXCHECK study waste resourcesI U Haq, P R Jackson, W W Yeo, et al.
Journal of Human Hypertension|June 1, 1995
Should cholesterol be measured in all hypertensives?I U Haq, W W Yeo, P R Jackson, et al.
Journal of Human Hypertension|August 1, 1995
Might non-pharmacological treatment disadvantage patients with hypertension?L E Ramsay, I U Haq, W W Yeo, et al.
Lancet (London, England)|January 18, 1997
Cholesterol and prevention of coronary heart diseaseI U Haq, P R Jackson, W W Yeo, et al.
Animal Reproduction Science|December 13, 2006
Serum hormonal, electrolytes and trace element profiles in the rutting and non-rutting one-humped male camel (Camelus dromedarius)Zia-Ur-Rahman, N Ahmad, Shazia Anwer Bukhari, et al.
Journal of Hypertension|May 2, 2001
Is coronary risk an accurate surrogate for cardiovascular risk for treatment decisions in mild hypertension? A population validationE J Wallis, L E Ramsay, I U Haq, et al.
Heart (British Cardiac Society)|April 30, 1999
Is the Framingham risk function valid for northern European populations? A comparison of methods for estimating absolute coronary risk in high risk menI U Haq, L E Ramsay, W W Yeo, et al.
JAMA|February 10, 1999
Coronary events with lipid-lowering therapy: the AFCAPS/TexCAPS trial. Air Force/Texas Coronary Atherosclerosis Prevention StudyI U Haq, E J Wallis, W W Yeo, et al.
Journal of Hypertension|December 23, 1999
Implication of recent trials with b-hydroxy-b-methylglutaryl coenzyme A reductase inhibitors for hypertension managementI U Haq, E J Wallis, P R Jackson, et al.
Pageof 4

Showing results (11-20 of 33) with videos related to

Sort By:
Pageof 4
QJM : Monthly Journal of the Association of Physicians|January 11, 2000
Prediction of coronary risk for primary prevention of coronary heart disease: a comparison of methodsI U Haq, L E Ramsay, P R Jackson, et al.
BMJ (Clinical Research Ed.)|July 22, 1995
Interventions in OXCHECK study waste resourcesI U Haq, P R Jackson, W W Yeo, et al.
Journal of Human Hypertension|June 1, 1995
Should cholesterol be measured in all hypertensives?I U Haq, W W Yeo, P R Jackson, et al.
Journal of Human Hypertension|August 1, 1995
Might non-pharmacological treatment disadvantage patients with hypertension?L E Ramsay, I U Haq, W W Yeo, et al.
Lancet (London, England)|January 18, 1997
Cholesterol and prevention of coronary heart diseaseI U Haq, P R Jackson, W W Yeo, et al.
Animal Reproduction Science|December 13, 2006
Serum hormonal, electrolytes and trace element profiles in the rutting and non-rutting one-humped male camel (Camelus dromedarius)Zia-Ur-Rahman, N Ahmad, Shazia Anwer Bukhari, et al.
Journal of Hypertension|May 2, 2001
Is coronary risk an accurate surrogate for cardiovascular risk for treatment decisions in mild hypertension? A population validationE J Wallis, L E Ramsay, I U Haq, et al.
Heart (British Cardiac Society)|April 30, 1999
Is the Framingham risk function valid for northern European populations? A comparison of methods for estimating absolute coronary risk in high risk menI U Haq, L E Ramsay, W W Yeo, et al.
JAMA|February 10, 1999
Coronary events with lipid-lowering therapy: the AFCAPS/TexCAPS trial. Air Force/Texas Coronary Atherosclerosis Prevention StudyI U Haq, E J Wallis, W W Yeo, et al.
Journal of Hypertension|December 23, 1999
Implication of recent trials with b-hydroxy-b-methylglutaryl coenzyme A reductase inhibitors for hypertension managementI U Haq, E J Wallis, P R Jackson, et al.
Pageof 4